HALO
Halozyme Therapeutics Inc
109.90$
+2.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 64.2% | 56.6% | 105.0% | – | 40.9% | 44.5% | 6.3% | 3.8% | 2.3% | 7.2% | 0.5% | 2.6% | 11.4% | 30.2% | 21.7% | 22.6% | 9.8% | 6.7% | 23.2% | 16.2% | 18.4% | 21.1% | 23.2% | 15.7% | 21.9% | |
| 35.8% | 43.4% | -5.0% | – | 59.1% | 55.5% | 93.7% | 96.2% | 97.7% | 92.8% | 99.5% | 97.4% | 88.6% | 69.8% | 78.3% | 77.4% | 90.2% | 93.3% | 76.8% | 83.8% | 81.6% | 78.9% | 76.8% | 84.3% | 78.1% | |
| – | – | – | – | 8,034.1% | 938.6% | 541.0% | 504.7% | 414.1% | 380.0% | 102.6% | 165.5% | 176.4% | 105.8% | 69.0% | 102.8% | 47.6% | 98.9% | 71.8% | 12.8% | 8.0% | 10.1% | 9.2% | 7.8% | 5.8% | |
| 192.1% | – | 302.6% | – | 2,685.8% | 704.1% | 293.6% | 167.0% | 111.2% | 111.0% | 32.3% | 58.6% | 59.0% | 47.7% | 29.6% | 31.3% | 17.0% | 40.0% | 39.4% | 17.1% | 11.4% | 21.7% | 18.0% | 15.2% | 14.8% | |
| 196.6% | 88.3% | 302.6% | – | 10,719.9% | 1,642.7% | 834.6% | 671.7% | 525.3% | 491.0% | 134.9% | 224.1% | 235.4% | 153.5% | 98.7% | 134.1% | 64.6% | 139.0% | 111.3% | 29.9% | 19.4% | 38.4% | 36.1% | 30.0% | 19.7% | |
| -160.9% | -44.9% | -307.7% | – | -10,660.7% | -1,587.3% | -740.9% | -575.5% | -427.6% | -398.2% | -35.4% | -126.7% | -146.8% | -83.7% | -20.3% | -56.7% | 25.6% | -45.7% | -34.5% | 53.9% | 62.2% | 40.5% | 40.7% | 54.3% | 58.4% | |
| 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 6.0% | 7.4% | 3.9% | 13.6% | 6.9% | 11.9% | 5.9% | 7.6% | 1.7% | 2.6% | 2.3% | 1.8% | 1.3% | |
| -160.6% | -73.4% | – | – | -10,435.9% | – | – | -555.9% | -426.9% | -390.8% | -35,248.9% | -126.5% | -152.3% | -90.8% | -23.9% | -69.4% | 19.5% | -52.5% | -36.9% | 48.3% | 56.1% | 37.7% | 42.0% | 54.9% | 33.4% | |
| – | 0.9% | 307.7% | – | -224.9% | -84.6% | -112.0% | -0.7% | – | -7.5% | -2.1% | -2.7% | 3.7% | 5.1% | 2.6% | 0.8% | -0.4% | 0.4% | 0.0% | 0.1% | -34.8% | 7.1% | 8.0% | 11.1% | 10.7% | |
| -160.6% | -74.4% | -307.7% | – | -10,435.9% | -1,502.6% | -628.9% | -555.2% | -426.9% | -390.8% | -35.2% | -126.5% | -152.3% | -90.8% | -23.9% | -70.2% | 19.9% | -52.9% | -36.9% | 48.2% | 90.8% | 30.6% | 34.0% | 43.7% | 22.7% | |
| -160.9% | -16.3% | -307.7% | – | -10,498.5% | -1,477.8% | -740.9% | -563.5% | -416.3% | -387.2% | -33.3% | -124.1% | -144.5% | -81.3% | -19.1% | -55.1% | 26.3% | -44.1% | -32.4% | 55.1% | 62.9% | 47.8% | 54.5% | 64.7% | 41.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.